LONDON (Reuters) - Britain's GlaxoSmithKline has asked its shareholders to vote at a meeting on Dec. 18 on its proposed major deal with Switzerland's Novartis , which will see the two pharmaceutical group trade more than $20 billion of assets.
via Reuters: Health News Read More Here..
No comments:
Post a Comment